These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 10047929)
1. L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers. Andreu N; Chalé JJ; Senard JM; Thalamas C; Montastruc JL; Rascol O Clin Neuropharmacol; 1999; 22(1):15-23. PubMed ID: 10047929 [TBL] [Abstract][Full Text] [Related]
2. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers. Hallam KT; Olver JS; McGrath C; Norman TR Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021 [TBL] [Abstract][Full Text] [Related]
3. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial. Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608 [TBL] [Abstract][Full Text] [Related]
4. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. Johnson MW; Suess PE; Griffiths RR Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817 [TBL] [Abstract][Full Text] [Related]
5. Dopamine and human information processing: a reaction-time analysis of the effect of levodopa in healthy subjects. Rihet P; Possamaï CA; Micallef-Roll J; Blin O; Hasbroucq T Psychopharmacology (Berl); 2002 Aug; 163(1):62-7. PubMed ID: 12185401 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of the effects of zopiclone and triazolam on the sleep of normal subjects]. Tiberge M; Calvet U; Khayi N; Delahaye C; Arbus L Encephale; 1988; 14(4):319-24. PubMed ID: 3058455 [TBL] [Abstract][Full Text] [Related]
8. Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences. Greenblatt DJ; Harmatz JS; von Moltke LL; Wright CE; Durol AL; Harrel-Joseph LM; Shader RI J Pharmacol Exp Ther; 2000 May; 293(2):435-43. PubMed ID: 10773013 [TBL] [Abstract][Full Text] [Related]
9. No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention. Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS J Psychopharmacol; 2006 Nov; 20(6):789-98. PubMed ID: 16478755 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. Berlin I; Warot D; Hergueta T; Molinier P; Bagot C; Puech AJ J Clin Psychopharmacol; 1993 Apr; 13(2):100-6. PubMed ID: 8463441 [TBL] [Abstract][Full Text] [Related]
11. An electromyographic analysis of the effect of levodopa on the response time of healthy subjects. Hasbroucq T; Tandonnet C; Micallef-Roll J; Blin O; Possamaï CA Psychopharmacology (Berl); 2003 Jan; 165(3):313-6. PubMed ID: 12451441 [TBL] [Abstract][Full Text] [Related]
12. Levodopa-induced drowsiness in healthy volunteers: results of a choice reaction time test combined with a subjective evaluation of sedation. Micallef-Roll J; Rihet P; Hasbroucq T; Possamaï C; Blin O Clin Neuropharmacol; 2001; 24(2):91-4. PubMed ID: 11307043 [TBL] [Abstract][Full Text] [Related]
13. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance. Takahashi H; Ishida-Yamamoto A; Iizuka H Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340 [TBL] [Abstract][Full Text] [Related]
14. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects. Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431 [TBL] [Abstract][Full Text] [Related]
15. Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating. Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS J Psychopharmacol; 2004 Sep; 18(3):388-94. PubMed ID: 15358983 [TBL] [Abstract][Full Text] [Related]
16. Oral triazolam pretreatment for intravenous sedation. Stopperich PS; Moore PA; Finder RL; McGirl BE; Weyant RJ Anesth Prog; 1993; 40(4):117-21. PubMed ID: 7943920 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study. Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544 [TBL] [Abstract][Full Text] [Related]
18. Midazolam and triazolam: hypnotic action and residual effects after a single bedtime dose. Borbély AA; Loepfe M; Mattmann P; Tobler I Arzneimittelforschung; 1983; 33(10):1500-2. PubMed ID: 6140018 [TBL] [Abstract][Full Text] [Related]
19. Cognitive impairments induced by triazolam in healthy volunteers: antagonism by a partial inverse agonist of benzodiazepine receptor. Warot D; Danjou P; Douillet P; Keane P; Puech AJ Therapie; 1994; 49(1):23-6. PubMed ID: 8091361 [TBL] [Abstract][Full Text] [Related]
20. Triazolam-amphetamine interaction: dissociation of effects on memory versus arousal. Mintzer MZ; Griffiths RR J Psychopharmacol; 2003 Mar; 17(1):17-29. PubMed ID: 12680736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]